TRIL anticorps (C-Term)

N° du produit ABIN6252855

Détail du produit anti-TRIL anticorps

Antigène: TRIL (TLR4 Interactor with Leucine-Rich Repeats (TRIL))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TRIL est non-conjugé

Application: Western Blotting (WB)

Purification: Protein A affinity chromatography

Immunogène: A recombinant protein fragment from the C-terminal region of human TRIL was used as the immunogen for this antibody.

Isotype: IgG

Information d'application

Indications d'application: Western blot: 2-5 μg/mL

Provided assay concentrations are suggestions only, antibody titration may be required for optimal results.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.1 mg/mL BSA and 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot and Store at -20C. Avoid freez-thaw cycles.

Détails sur TRIL

Antigène: TRIL (TLR4 Interactor with Leucine-Rich Repeats (TRIL))

Autre désignation: TRIL (TRIL Produits)

Sujet: TRIL or TLR4 interactor with leucine rich repeats, is a protein encoded by the human KIAA0644 gene. TRIL protein sequence is highly conserved across species. It is expressed in a number of tissues with highest expression in brain, ovary, small intestine and spleen. TRIL is an accessory molecule that interacts with TLR3 and endosomal TLR4, enhancing their interaction with their ligands, poly(I:C) and LPS, and increasing the production of type I interferons in the innate immune response.

ID gène: 9865

UniProt: Q7L0X0

Pathways: Activation of Innate immune Response, Production of Molecular Mediator of Immune Response